SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Two affiliated venture funds, Atlas Venture Fund XI and Atlas Venture…

Dyne Therapeutics, Inc. · 144 filed Apr 20, 2026 at 16:44 ET

At the news

BEARISHIMPACT 6/10

144 filed Apr 20, 2026 at 16:44 ET

Two affiliated venture funds, Atlas Venture Fund XI and Atlas Venture Opportunity Fund I, filed Form 144 notices to sell a combined 198,926 shares of Dyne Therapeutics stock, representing an intent to sell approximately $2.9 million worth of shares. The sales are planned under Rule 144 following private placement acquisitions in 2020.

  • Atlas Venture Fund XI filed to sell 142,571 shares, valued at approximately $2.05 million based on recent market price
  • Atlas Venture Opportunity Fund I filed to sell 56,355 shares, valued at approximately $815,000
  • Total proposed sale: 198,926 shares worth ~$2.87 million
  • Shares were acquired in private placements in July and August 2020

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access